Revlimid capsules
Showing 1 - 25 of 1,966
Revlimid® Capsules General Drug Use-results Surveillance
Recruiting
- Lymphoma Nonhodgkin
-
Japan, JapanLocal Institution
Jun 22, 2022
Analyze Occurrence of Transformation From Myelodysplastic
Completed
- Myelodysplastic Syndromes
- Leukemia, Myeloid, Acute
-
Kobe, Hyogo, JapanShinko Hospital
Jun 13, 2022
Lenalidomide in Combination With Dexamethasone in Clinical
Active, not recruiting
- Multiple Myeloma
-
Kirchdorf, Austria
- +11 more
May 16, 2022
Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)
Active, not recruiting
- Leukemia
- Lymphoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
B-cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Placebo)
Completed
- B-cell Chronic Lymphocytic Leukemia
- Lenalidomide
- Placebo
-
Phoenix, Arizona
- +240 more
Nov 24, 2021
Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)
Recruiting
- Relapsed/Refractory Follicular Lymphoma
- Marginal Zone Lymphoma
- Zanubrutinib
- +3 more
-
Westbury, New YorkClinical Research Alliance, Inc.
Nov 14, 2022
Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)
Not yet recruiting
- Non-Hodgkin Lymphoma
- Tafasitamab
- +3 more
-
Cologne, GermanyUniversity of Cologne
Oct 14, 2022
Multiple Myeloma Trial (RP followed by MPR)
Active, not recruiting
- Multiple Myeloma
- RP followed by MPR
- (no location specified)
Mar 24, 2022
Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)
Completed
- Helicobacter Pylori Infection
- TNP-2198
- +2 more
-
Chang chun, Jilin, ChinaThe First Hospital of Jilin University
Oct 7, 2023
Plasma Cell Myeloma Trial in United States (isatuximab SAR650984, lenalidomide, dexamethasone)
Active, not recruiting
- Plasma Cell Myeloma
- isatuximab SAR650984
- +2 more
-
San Francisco, California
- +4 more
Jun 16, 2022
Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)
Completed
- Helicobacter Pylori Infection
- TNP-2198
- +2 more
-
Chang chun, Jilin, ChinaThe First Hospital of Jilin University
Oct 7, 2023
Bioequivalence Trial in Edison (Oseltamivir Phosphate 75 mg capsules, Tamiflu capsules 75 mg)
Completed
- Bioequivalence
- Oseltamivir Phosphate 75 mg capsules
- Tamiflu capsules 75 mg
-
Edison, New JerseyAustarpharma Llc
Feb 1, 2023
Colorectal Cancer, Clostridioides Difficile Infection, Diarrhea Trial in Koscierzyna (Sanprobi IBS®)
Recruiting
- Colorectal Cancer
- +2 more
- Sanprobi IBS®
-
Kościerzyna, PolandUnit of Surgery with Unit of Oncological Surgery in Koscierzyna
Aug 24, 2023
Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms Trial in China (Silodosin Capsules, Ningmitai capsule,
Recruiting
- Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
- Silodosin Capsules
- +2 more
-
Beijing, Beijing, China
- +7 more
Sep 21, 2022
H.Pylori Infection Trial in Beijing (Rifasutenizol capsules, Rabeprazole sodium enteric-coated tablets, Amoxicillin Capsules)
Not yet recruiting
- H.Pylori Infection
- Rifasutenizol capsules
- +7 more
-
Beijing, ChinaPeking University Third Hospital
May 3, 2023
Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Epcoritamab
- Lenalidomide
- (no location specified)
Jan 20, 2023
Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)
Terminated
- Chronic Lymphocytic Leukemia(CLL)
- Small Lymphocytic Lymphoma
-
Hackensack, New JerseyHackensack University Medical Center
Jun 24, 2022
Glioblastoma Trial in Beijing (PLB1001, Temozolomide, Cisplatin combined with Etoposide)
Active, not recruiting
- Glioblastoma
- PLB1001
- +2 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital,Capital Medical University
Oct 27, 2023
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Netopitam Palonosetron capsules and dexamethasone
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital and Research Institute
Oct 22, 2023
Locally Advanced or Metastatic NSCLC Trial in Nanjing (Rifampicin; ASK120067, ASK120067;itraconazole)
Completed
- Locally Advanced or Metastatic NSCLC
- Rifampicin; ASK120067
- ASK120067;itraconazole
-
Nanjing, Jiangsu, ChinaDrum Tower Hospital of Nanjing University School of Medical
Nov 20, 2022
Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)
Not yet recruiting
- Platinum-resistant Ovarian Cancer
- Oral Topotecan Combined With Anlotinib
-
Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023
Drug Use Trial in Jakarta Pusat (Omeprazole 20 mg Capsules)
Completed
- Drug Use
- Omeprazole 20 mg Capsules
-
Jakarta Pusat, DKI Jakarta, IndonesiaPT Pharma Metric Labs
May 8, 2023
Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)
Recruiting
- Newly Diagnosed Multiple Myeloma
- Daratumumab
- +4 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Dec 29, 2022